Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Watkins-Conti Products
AddedFeb 16, 2024
UpdatedJun 18, 2026
Watkins-Conti Products

Watkins-Conti Products

Watkins-Conti Products: Effective women's healthcare solutions targeting causes & symptoms of incontinence.

HQ
Edmond, OK, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Watkins-Conti Products, founded with a mission to revolutionize women's healthcare, focuses on providing effective solutions for pelvic health issues, particularly incontinence. The company aims to address both the causes and symptoms of stress urinary incontinence through innovative products. Their flagship product, Yōni.Fit, is designed to offer a new option for managing this condition and is currently pending FDA approval after successful clinical trials conducted by leading Urogynecologists at institutions like Stanford, NYU, and Jefferson Health.

Notable figures affiliated with Watkins-Conti Products include Dr. Darren Goff, MD, an Obstetrics and Gynecology specialist who has endorsed Yōni.Fit as a groundbreaking solution for urethral support. The company has garnered significant attention for its clinical rigor and potential impact on women's health. With its pioneering approach and strong clinical backing, Watkins-Conti Products is poised to make a substantial impact on the market for women's pelvic health solutions.

Watkins-Conti Products - Similar Companies

Incont logo

Incont

incont.org

Athena Feminine Technologies logo

Athena Feminine Technologies

Flyte logo

Flyte

pelvital.com

UroCure logo

UroCure

urocure.com

CollaMedix logo

CollaMedix

collamedixinc.com

Privy logo

Privy

privywoman.com

Emkinetics logo

Emkinetics

emkinetics.com

InControl Medical logo

InControl Medical

Global Continence logo

Global Continence

Liv Labs logo

Liv Labs

livlabsfitness.com

OYA Femtech Apparel logo

OYA Femtech Apparel

wearoya.com

Uromedica logo

Uromedica

uromedica-inc.com

Elidah logo

Elidah

elidah.com

GT Urological logo

GT Urological

CathConnect logo

CathConnect

cathconnect.com

Watkins-Conti Products - Quick Facts

Who are Watkins-Conti Products' competitors?

Companies similar to Watkins-Conti Products include Incont, Athena Feminine Technologies, Flyte and UroCure.

When was Watkins-Conti Products founded?

Watkins-Conti Products was founded in 2015.

Where is Watkins-Conti Products' headquarters located?

Watkins-Conti Products' headquarters is located in Edmond, OK, US.

How much has Watkins-Conti Products raised to-date?

As of Dec 27, 2022, Watkins-Conti Products has raised a total of $2.9M (USD).

How many employees does Watkins-Conti Products have?

Watkins-Conti Products has 35 employees as of Feb 4, 2024.

Watkins-Conti Products - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Healthcare
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 310000Manufacturing
  • 315000Apparel Manufacturing
  • 315200Cut and Sew Apparel Manufacturing
SIC
  • 2300Apparel And Other Finished Products Made From Fabrics And Similar Material
  • 2380Miscellaneous Apparel And Accessories
  • 2389Apparel And Accessories, Not Elsewhere Classified
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified